Dimensional Fund Advisors LP Decibel Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
SELL
$1.86 - $3.54 $12,525 - $23,838
-6,734 Reduced 16.29%
34,607 $70,000
Q3 2022

Nov 10, 2022
BUY
$3.82 - $5.61 $157,922 - $231,923
41,341 New
41,341 $143,000

About Decibel Therapeutics, Inc.

DBTX Quotes by TradingView
  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email